Accessibility Menu
Stereotaxis Stock Quote

Stereotaxis (NYSEMKT: STXS)

$3.10
(2.0%)
+0.06
Price as of October 23, 2025, 4:00 p.m. ET

KEY DATA POINTS

Current Price
$3.1
Daily Change
(2.0%) +$0.06
Day's Range
$3 - $3.12
Previous Close
$3.1
Open
$3.06
Beta
1.17
Volume
296,358
Average Volume
588,187
Market Cap
282.3M
Market Cap / Employee
$3.10M
52wk Range
$1.54 - $3.59
Revenue
-
Gross Margin
0.50%
Dividend Yield
N/A
EPS
-$0.28
CAPs Rating
-
Industry
Healthcare Equipment and Supplies

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Stereotaxis Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
STXS+61.46%-8.55%-1.77%-96%
S&P+14.5%+93.32%+14.09%+530%

Stereotaxis Company Info

Stereotaxis, Inc. designs, manufactures and markets robotic magnetic navigation systems for use in a hospital's interventional surgical suite to enhance the treatment of arrhythmias and coronary artery disease. Its products include the Genesis RMN System, the Odyssey Solution, and related devices. The firm also offers the Stereotaxis Imaging Model S x-ray System. The company was founded in June 1990 and is headquartered in St. Louis, MO.

News & Analysis

Financial Health

General

Q2 2025YOY Change
Revenue$8.80M95.4%
Gross Profit$4.58M38.2%
Gross Margin52.05%-21.5%
Market Cap$182.32M21.2%
Market Cap / Employee$1.31M0.0%
Employees13913.9%
Net Income-$3.83M34.4%
EBITDA-$3.58M39.2%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q2 2025YOY Change
Net Cash$6.97M-54.1%
Accounts Receivable$4.39M57.9%
Inventory9.63.5%

Liabilities

Q2 2025YOY Change
Long Term Debt$5.12M6.2%
Short Term Debt$0.61M32.1%

Ratios

Q2 2025YOY Change
Return On Assets-60.51%-11.3%
Return On Invested Capital-61.60%-25.5%

Cash Flow

Q2 2025YOY Change
Free Cash Flow-$3.76M-20.8%
Operating Free Cash Flow-$3.73M-20.9%

Valuation

MetricQ3 2024Q4 2024Q1 2025Q2 2025YoY Change
Price to Book14.9117.8624.7063.28516.74%
Price to Sales6.967.355.625.86-9.56%
Price to Tangible Book Value14.91-104.91-29.78-22.71-321.27%
Enterprise Value to EBITDA-29.20-27.11-27.87-53.28109.80%
Return on Equity-106.5%-144.2%-179.8%-198.6%109.32%
Total Debt$6.14M$6.01M$5.87M$5.73M8.45%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.